Last reviewed · How we verify

NCT04891926: HODI

Hormonal Influences on Diuresis

Completed NA Last updated 19 May 2021
What this trial tests

NA trial testing ICIQ FLUTS Questionaires in Nocturia in 70 participants. Completed in 30 September 2018.

Timeline
1 May 2015
Primary endpoint
30 September 2018
30 September 2018

Quick facts

Lead sponsorUniversity Hospital, Ghent
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment70
Start date1 May 2015
Primary completion30 September 2018
Estimated completion30 September 2018

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Ghent

Who can join

40 and older, female only, with Nocturia or Menopause. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to observe the effect of hormonal treatment (oral or transdermal substitution therapy) on diuresis (salt and water diuresis) and lower urinary tract symptoms (LUTS) in postmenopausal women

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Does hormonal therapy affect the bladder or the kidney in postmenopausal women with and without nocturnal polyuria: Results of a pilot trial?
    Pauwaert K, Bruneel E, Van Laecke E, Depypere H, et al · · 2022 · cited 2× · PMID 35550708 · DOI 10.1016/j.maturitas.2022.01.009

Verify or expand the search:

Other recruiting trials for Nocturia

Currently open trials in the same condition.

Other University Hospital, Ghent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04891926.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing